P505: SAFETY AND EFFICACY OF CASEIN KINASE 1Α AND CYCLIN DEPENDENT KINASE 7/9 INHIBITION IN PATIENTS WITH RELAPSED OR REFRACTORY AML: A PHASE 1, FIRST-IN-HUMAN STUDY OF BTX-A51

• B. J. Ball,
• G. Borthakur,
• A. Stein,
• K. W. Chan,
• D. Thai,
• E. M. Stein

Affiliations

B. J. Ball

1 Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte

G. Borthakur

2 Leukemia, MD Anderson Cancer Center, Houston

A. Stein

1 Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte

K. W. Chan

3 BioTheryx, San Diego

D. Thai

3 BioTheryx, San Diego

E. M. Stein

4 Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, United States of America